Avanos Medical, Inc.AVNSNYSE
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-51.6%
5Y CAGR+15.3%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-51.6%/yr
Annual compound
5Y CAGR
+15.3%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202582.88%
2024-541.35%
2023-223.15%
2022730.77%
2021122.81%
202040.63%
2019-178.69%
2018-27.81%
201798.82%
2016109.29%